LifeStance Health EBITDA Margin 2020-2024 | LFST
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for LifeStance Health (LFST) over the last 10 years. The current EBITDA margin for LifeStance Health as of March 31, 2024 is .
| LifeStance Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-03-31 | $1.10B | $-0.09B | -7.79% |
| 2023-12-31 | $1.06B | $-0.11B | -10.03% |
| 2023-09-30 | $1.01B | $-0.12B | -12.24% |
| 2023-06-30 | $0.96B | $-0.09B | -9.27% |
| 2023-03-31 | $0.91B | $-0.10B | -11.43% |
| 2022-12-31 | $0.86B | $-0.14B | -16.16% |
| 2022-09-30 | $0.82B | $-0.21B | -25.58% |
| 2022-06-30 | $0.78B | $-0.30B | -38.61% |
| 2022-03-31 | $0.73B | $-0.29B | -39.97% |
| 2021-12-31 | $0.67B | $-0.23B | -34.43% |
| 2021-09-30 | $0.60B | $-0.12B | -20.13% |
| 2021-06-30 | $0.52B | $0.00B | 0.76% |
| 2021-03-31 | $0.45B | $0.05B | 10.74% |
| 2020-12-31 | $0.38B | $0.04B | 11.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.877B | $1.056B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.800B | 0.00 |
| Quest Diagnostics (DGX) | United States | $15.206B | 15.72 |
| DaVita (DVA) | United States | $12.153B | 15.10 |
| Encompass Health (EHC) | United States | $8.638B | 22.11 |
| Chemed (CHE) | United States | $8.214B | 25.46 |
| Elanco Animal Health (ELAN) | United States | $7.131B | 18.50 |
| Option Care Health (OPCH) | United States | $4.815B | 18.22 |
| RadNet (RDNT) | United States | $4.353B | 90.65 |
| Amedisys (AMED) | United States | $3.000B | 21.25 |
| Astrana Health (ASTH) | United States | $2.272B | 30.73 |
| Addus HomeCare (ADUS) | United States | $1.901B | 27.19 |
| U.S Physical Therapy (USPH) | United States | $1.393B | 37.27 |
| Pennant (PNTG) | United States | $0.697B | 36.81 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.531B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.223B | 0.00 |
| Daxor (DXR) | United States | $0.045B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.020B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.019B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.014B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| Ontrak (OTRK) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.002B | 0.00 |